Tango Therapeutics, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
TNGX on Nasdaq
Industry
Pharmaceutical Preparations
Location
201 Brookline Avenue, Suite 901, Boston, MA

Insiders trading volume in the past year

Tango Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Third Rock Ventures IV, L.P. 10%+ Owner $178M -$25.5M -12.6% Sep 13, 2024
Boxer Capital, LLC Other* $139M Oct 13, 2023
BCTG Holdings, LLC 10%+ Owner $58.6M Aug 10, 2021
EcoR1 Capital, LLC 10%+ Owner $31M -$8.44M -21.4% Nov 6, 2024
Barbara Weber Chief Executive Officer, Director $19.4M -$115K -0.59% Feb 6, 2024
Boxer Capital Management, LLC Other* $11.3M -$20.1M -64% Nov 6, 2024
Daniella Beckman Chief Financial Officer $1.67M -$46.9K -2.73% Feb 6, 2024
Third Rock Ventures VI, L.P. Director $1.63M Aug 11, 2023
Adam Crystal President, Research & Development $1.51M -$105K -6.53% Feb 6, 2024
Alan Huang Chief Scientific Officer $1.41M Mar 1, 2023
MVA Investors, LLC Other* $944K -$4.62M -83% Jun 28, 2024
Douglas Barry General Counsel $555K -$35K -5.92% Feb 6, 2024
Braslyn Ltd. 10%+ Owner $226K Aug 10, 2021
Mace Rothenberg Director $118K +$74K +168% Nov 14, 2024
John B. Ketchum Director $112K Jun 5, 2024
Alexis Borisy Director $85.6K Jun 5, 2024
Malte Peters Director $81.1K Jun 5, 2024
Lesley Ann Calhoun Director $45K +$36K +400% Jun 5, 2024
Reid M. Huber Director $42K Jun 6, 2023
Marc Rudoltz Chief Medical Officer Nov 1, 2021
Kanishka Pothula Director Nov 6, 2023
Davis Aaron I. Other* Sep 3, 2024
Aaron Weitzman Chief Medical Officer Dec 1, 2022

Recent Insider Transactions by Companies or Individuals for Tango Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.